Investigation of the contributions of nitric oxide and prostaglandins to the actions of endothelins and sarafotoxin 6c in rat isolated perfused lungs

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 1931-1938

  Lal, H ^a   Woodward, B ^a   Williams, K I ^a  

^a University of Bath   (United Kingdom)

Author keywords

Bronchoconstriction; ETs and SX6C; Nitric oxide; Prostanoids; Pulmonary vasoconstriction vasodilatation; Rat lung

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR SUBTYPE; SARAFOTOXIN;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; BRONCHOSPASM; CONTROLLED STUDY; LUNG INFLATION; LUNG PERFUSION; LUNG VASOCONSTRICTION; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0029786941     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15627.x     Document Type: Article

References (36)

1. BARNES, P.J. (1994). Endothelins and pulmonary disease. J. Appl. Physiol., 77, 1051-1059.
2. A receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J. Cardiovasc. Pharmacol., 22, 39-43.
3. 2 on some isolated smooth muscle preparations. Br. J. Pharmacol., 73, 773-778.
4. DENUCCI, G., THOMAS, R., D'ORLÉANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressure effects of circulating endothelin are limited by its removal in the pulmonary circulation and by release of prostacyclin and endothelium derived relaxing factors. Proc. Natl Acad. Sci. U.S.A., 85, 9797-9800.
5. DOUGLAS, S.A., MEEK, T.D. & OHLSTEIN, E.H. (1994). Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol. Sci., 15, 313-316.
6. EDDAHIBI, S., RAFFESTIN, B., CLOZEL, M., LEVAME, M. & ADNOT, S. (1995). Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am. J. Physiol., 268, H828-H835.
7. EDDAHIBI, S., SPRINGALL, D., MANNAN, M., CARVILLE, C., CHABRIER, P.E., LEVAME, M., RAFFESTIN, B., POLAK, J. & ADNOT, S. (1993). Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia. Am. J. Physiol., 265, L571-L580.
8. EGUCHI, S., HIRATA, Y., IMAI, T. & MARUMO, F. (1993). Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature. Endocrinology, 132, 524-529.
9. B receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle. Br. J. Pharmacol., 112, 887-894.
10. ERCAN, Z.S., KILINC, M., ZAZAR, O., KORKUSUK, P. & TURKER, R.K. (1993). Endothelin-1-induced oedema in rat and guinea-pig isolated perfused lungs. Arch. Int. Pharmacodyn., 323, 74-84.
11. FILEP, G.J., BATTISTINI, B. & SIROIS, P. (1993). Induction by endothelin-1 of epithelium-dependent relaxation of guinea-pig trachea in vitro: role for nitric oxide. Br. J. Pharmacol., 109, 637-644.
12. G-monomethyl-L-arginine. Br. J. Pharmacol., 110, 1003-1008.
13. GAO, Y., ZHOU, H. & RAJ, U. (1995). Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Circ. Res., 76, 559-565.
14. HAY, D.W.P. & GOLDIE, R.G. (1995). Role of endothelin in pulmonary disease. In Endothelin: Role in Health and Disease. ed. Gulati, A. pp. 251-278. USA: Harwood Academic Publishers.
15. KITAZONO, T., HEISTAD, D.D. & FARACI, F.M. (1995). Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo. J. Pharmacol. Exp. Ther., 273, 1-6.
16. KEEN, M., PICKERING, S.A.W. & HUNT, J.A. (1990). Modulation of the bradykinin-stimulated release of prostacyclin from endothelial cells. Br. J. Pharmacol., 101, 524P.
17. LAL, H., WOODWARD, B. & WILLIAMS, K.I. (1994). Differential effects of agents on bronchial and vascular tone and lung weight in the rat isolated perfused lung. Pulmonary Pharmacol., 7, 271-278.
18. LAL, H., WOODWARD, B. & WILLIAMS, K.I. (1995a). Actions of endothelins and sarafotoxin 6c in the rat isolated perfused lung. Br. J. Pharmacol., 115, 653-659.
19. LAL, H., WOODWARD, B. & WILLIAMS, K.I. (1995b). Low concentrations of BQ123 potentiate the pulmonary vascular and bronchial actions of endothelin-1 in the rat isolated perfused lung. Br. J. Pharmacol., 114, 51P.
20. LAL, H., WOODWARD, B. & WILLIAMS, K.I. (1995c). Effects of nitroL-arginine (L-NOARG) on endothelin-1 (ET-1) and sarafotoxin 6c (SX6C) responses in rat isolated perfused lungs. Br. J. Pharmacol., 116, 192P.
21. LE MONNIER DE GOUVILLE, A-C., LIPPTON, H., COCHEN, G., CAVERO, I. & HYMAN, A. (1990). Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration. J. Pharmacol. Exp. Ther., 254, 1024-1028.
22. LEMONNIER DE GOUVILLE, A-C. & CAVERO, I. (1991). Cross-tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin. Br. J. Pharmacol., 104, 77-84.
23. LIPPTON, H.L., HAUTH, T.A., COHEN, G.A. & HYMAN, A.L. (1993). Functional evidence for different endothelin receptors in the lung. J. Appl. Physiol., 75, 38-48.
24. B receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J. Cardiovasc. Pharmacol., 23, 838-845.
25. G-nitroarginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br. J. Pharmacol., 99, 408-412.
26. B-like receptors. Biochem. Biophys. Res. Commun., 184, 100-106.
27. NAMIKI, A., HIRATA, Y., ISHIKAWA, M., MOROI, M., AIKAWA, J. & MACHI, K. (1992). Endothelin-1 and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sci., 50, 677-682.
28. PINHEIRO, J.M.B. & MALIK, A.B. (1993). Mechanisms of endothelin-1-induced pulmonary vasodilation in neonatal pigs. J. Physiol., 469, 739-752.
29. RODMAN, D.M., STELZNER, T.J., ZAMORA, M.R., BONVALLET, S.T., OKA, M., SATO, K., O'BRIEN, R.F. & MCMURTRY, I.F. (1992). Endothelin-1 increases the pulmonary microvascular pressure and causes pulmonary edema in the salt solution but not blood-perfused rat lungs. J. Cardiovasc. Pharmacol., 20, 658-663.
30. SOKOLOVSKY, M., AMBAR, I. & GALRON, R.A. (1992). Novel subtypes of endothelin receptors. J. Biol. Chem., 267, 20551 20554.
31. STEWART, D.J., LEVY, R.D., CERNACEK, P. & LANGLEBEN, D. (1991). Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease. Ann. Intern. Med., 114, 464 469.
32. WARNER, T.D., MITCHELL, J.A., DENUCCI, G. & VANE, J.R. (1989). Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of rat and rabbit. J. Cardiovasc. Pharmacol., 13, S85-S88.
33. WILLIAMS, D.L., JONES, K.L., PETTIBONE, D.J., LIS, E.V. & CLINESCHMIDT, B.V. (1991). Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun., 175, 556-561.
34. XUE, C., RENGASAMY, A., LECRAS, T.D., KOBERNA, P.A., DAILEY, G.C. & JOHNS, R.A. (1994). Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am. J. Physiol., 267, L667-L678.
35. ZELLERS, T.M., MCCORMICK, J. & WU, Y. (1994). Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins. Am. J. Physiol., 267, H139-H147.
36. ZI-QIANG, D., SHAO-HUA, L. & MEI-ZHEN, J. (1994). Preservation of pulmonary vascular permeability barrier by endothelium-derived relaxing factor. Chin. J. Pharmacol. Sci., 10, 268-273.